Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  • Equipment
  1. Outputs

Amino Acid Infusion for Perioperative Functional Renal Protection: A Meta-analysis

Academic Article
Publication Date:
2024
Short description:
Amino Acid Infusion for Perioperative Functional Renal Protection: A Meta-analysis / Pruna, A., Losiggio, R., Landoni, G., Kotani, Y., Redaelli, M.B., Veneziano, M., Lee, T.C., Zangrillo, A., Gaudino, M.F.L., Bellomo, R., Monaco, F., Belletti, A., Nisi, F.G., Fominskiy, E.. - In: JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA. - ISSN 1053-0770. - 38:12(2024), pp. 3076-3085. [10.1053/j.jvca.2024.08.033]
abstract:
Objectives: Acute kidney injury (AKI) is a common perioperative complication. To date, no single intervention has been proven effective for AKI prevention in this setting. However, intravenous amino acids (AA) administration may recruit renal functional reserve and, thereby, attenuate the perioperative loss of the glomerular filtration rate. Design: We performed a meta-analysis to assess the efficacy of AA infusion for perioperative renal functional protection. Setting and Participants: We performed a meta-analysis of controlled studies in perioperative patients evaluating intravenous AA infusion versus any comparator. Measurements: The primary outcome was AKI at longest follow-up. We performed a random effects meta-analysis on the relative risk (RR) scale to assess the effect of AA infusion. We used a Bayesian approach to estimate the probability of benefit (RR < 1) for the primary outcome. Secondary outcomes included renal replacement therapy, serum creatinine, and estimated glomerular filtration rate. Tertiary outcomes included mechanical ventilation duration, intensive care unit and hospital length of stay and mortality (PROSPERO: CRD42024547225). Results: We identified 15 studies (14 randomized controlled trials and 1 prospective before–after study) reporting at least one outcome of interest (4,544 patients), with 6 studies (4,084 patients) reporting the primary outcome. AKI occurred 504 of 2,041 (24.7%) in AA patients versus 614 of 2,041 (30.1%) in controls (RR, 0.66; 95% confidence interval, 0.47–0.94; I2 = 50%; p = 0.02), which corresponded with a 99.1% probability of AKI reduction with AA. Moreover, consistent with these findings, AA decreased serum creatinine and hospital length of stay and increased the estimated glomerular filtration rate. Conclusions: This meta-analysis suggests that AA administration likely decreased the perioperative incidence of AKI.
Iris type:
1.1 Articolo in rivista
List of contributors:
Pruna, Alessandro; Losiggio, Rosario; Landoni, Giovanni; Kotani, Yuki; Redaelli, Martina Baiardo; Veneziano, Marta; Lee, Todd C.; Zangrillo, Alberto; Gaudino, Mario F. L.; Bellomo, Rinaldo; Monaco, Fabrizio; Belletti, Alessandro; Nisi, Francesco Giuseppe; Fominskiy, Evgeny
Authors of the University:
LANDONI GIOVANNI
ZANGRILLO ALBERTO
Handle:
https://iris.unisr.it/handle/20.500.11768/174698
Published in:
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
Journal
  • Overview

Overview

URL

https://www.sciencedirect.com/science/article/pii/S105307702400572X?via=ihub
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.11.0.0